Related Experiment Video
Updated: Jun 18, 2026

Brain Morphology of Cannabis Users With or Without Psychosis: A Pilot MRI Study
Published on: August 18, 2020
Severity-dependent alterations of functional network segregation and integration in tobacco use disorder
Guohao Lu1, Longyao Ma1, Yichen Guo1
1Department of Magnetic Resonance Imaging, the First Affiliated Hospital of Zhengzhou University, PR China; Zhengzhou Key Laboratory of Brain Function and Cognitive Magnetic Resonance Imaging, PR China; Henan Engineering Technology Research Center for Detection and Application of Brain Function, PR China; Henan Engineering Research Center of Medical Imaging Intelligent Diagnosis and Treatment, PR China; Henan Key Laboratory of Imaging Intelligence Research, PR China; Henan Engineering Research Center of Brain Function Development and Application, PR China.
Background:
Previous research on brain network topology in Tobacco Use Disorder (TUD) has been inconsistent, likely due to overlooking the heterogeneity of addiction severity. Consequently, how these topological alterations manifest across different smoking severities is not fully understood.
Methods:
Resting-state functional magnetic resonance imaging (fMRI) and clinical data were collected from 102 males (24 heavy smokers, 36 light smokers, 42 healthy controls). Based on the fMRI data, we computed global graph metrics and applied Network-Based Statistics (NBS) analysis to identify abnormal subnetworks, and performed correlation analyses between global graph metrics and clinical scales. A Support Vector Machine (SVM) classifier was constructed using functional connectivity (FC) strength, graph metrics, and multi-scale fusion features to discriminate the severity of smoking at the individual level within a rigorous repeated stratified nested cross-validation framework.
Results:
Graph-theory analysis revealed that patients with Tobacco Use Disorder (TUD) exhibited significant large-scale topological reorganization, characterized by increased global integration, indexed by higher global efficiency (Eglob), and reduced local segregation, indexed by a lower clustering coefficient (Cp). Network-Based Statistics (NBS) identified two distinct subnetworks showing reduced connectivity in the TUD group, primarily involving the default mode, limbic, and sensorimotor networks. Subgroup analyses further demonstrated a severity-dependent pattern of network alterations. Light smokers showed increased Eglob with relatively preserved Cp, whereas heavy smokers exhibited a significant reduction in Cp accompanied by more extensive disruption of connectivity across distributed higher-order networks. In contrast, no significant subnetworks were detected in the light smoker group. Importantly, correlation analysis revealed a significant negative association between Cp and Fagerström Test for Nicotine Dependence (FTND) scores. Finally, a multi-scale machine learning model integrating network features and evaluated using 10 × 5 repeated stratified nested cross-validation achieved optimal classification of smoking severity (ensemble AUC = 0.8380), outperforming models based on single-modality features.
Conclusion:
TUD involves a severity-dependent pathophysiological gradient, which may reflect a hypothesized shift from compensatory strengthening of global integration in light smokers to advanced-severity weakening of local network organization in heavy smokers. The severity-dependent reduction in local segregation, together with widespread hypoconnectivity, suggests multi-scale network disruption. These multi-scale functional network features provide preliminary evidence supporting their potential utility for severity stratification in TUD.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Dependence
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
